912
PŘEHLEDOVÉ3695202011151111167232285340403465523580
ČLÁNKY4301202011154107169233293349
/4675202011133
REVIEW4733202011157113173207263347
ARTICLES5105202011158120175208264317372423
Perioperační36723230974382109128173220261288328364409428
management411732309767106151190235276344385430456
pacientů45903230974686122141182227254298
léčených4905323097196097137182219255300
glifloziny5222323097456483105126170205224269306
|5584198011126
167565419801113683126
/23738043010732
Anest24508043010752100145178207
intenziv267780430107196794136184221240282
Med.29788043010770115165181
2024;35(3):162-1673178804301074487129169183227269291333354369406445487513551590632
/38558043010731
ANESTEZIOLOGIE39528043010753112155200245290342362424467527586607650
A46248043010752
INTENZIVNÍ4698804301071978123168226276296345405426
MEDICÍNA51458043010770114174195248268327381
www.aimjournal.cz4258043010765133201214257275349367415463490539579598614654693
27.425553085367180
Bhatt5215540833574106128152
DL,689554083457791
Szarek796554083326194115149180
M,9915540835568
Pitt107555408335507296
B,11875540833548
Cannon12515540834072111148187225
CP,1492554083407580
Leiter1587554083326681103137158
LA,1761554083317589
McGuire18665540835486131169185206240
DK,2121554083468196
et22335540833456
al;2305554083314759
SCORED23795540833373119155189234
Investigators.2629554083145284118145168183222254425654083215879106119
Sotagliflozin556654083327091124162177191209225263290306343
in9116540831552
Patients975654083356688103137174195222
with1210654083506587124
Diabetes1347654083456091130165186220246
and16056540833269107
Chronic1725654083397697134172186218
Kidney1955654083345089126160191
Disease.2159654083456085120151177211223
N239565408344
Engl24516540833269108123
J258665408324
Med.26226540835489128140
20212775654083336799130
Jan425754083245694
14;384(2):129-139.535754083346577112146182202236254266295325359383414444477488
doi:1038754083387792104
10.1056/NEJMoa2030186.1157754083356679109141175209234280313340395433466501535568602634665701714
Epub18867540833372110149
202020507540833569102136
Nov22017540834583115
16.2331754083346679
PMID:24257540833589105150163
33200891.2604754083346799133170205239271281
28.425853085367288
Bhatt5328540833574106128152
DL,703854083457791
Szarek813854083336195116150180
M,10128540835468
Steg1099854083325387127
PG,1245854083357993
Cannon13568540834073111149187226
CP,1601854083407580
Leiter1700854083316580103136158
LA,1876854083327589
McGuire19848540835587132170185206240
DK,2243854083458196
et23588540833456
al;2433854083324759
SOLOIST‑WHF25118540833280112158174206240258316361394
Trial42595408332496596112
Investigators.549954083155384118144167182221253274311332359372
Sotagliflozin934954083327092124163178193211227265293308346
in12939540831452
Patients1357954083356788103138176197224
with1594954083506688126
Diabetes1732954083456192131167189222249
and19939540833269108
Recent21149540833570102135173194
Worsening23219540835793115142176214229267305
Heart26399540834478110131155
Failure.28079540833261764251054083155273108120
N565105408344
Engl62910540833371110125
J774105408324
Med.81810540835590129142
202198010540833468101133
Jan11331054083245694
14;384(2):117-128.12471054083346577112146183202236254266296323353371402432466479
doi:17461054083387792104
10.1056/NEJMoa2030183.18701054083346678109140175209234280313340394433466500534567602634665699711
Epub260110540833372110149
2020277010540833468101135
Nov42511540834583115
16.5551154083346679
PMID:64911540833589105150163
33200892.8281154083346799133170205239273285
29.4251253085367285
Mehta52512540835490128149182
PB,7221254083357083
Robinson81912540833674114129167193232270
A,110412540834155
Burkhardt11741254083357394125164196217255278
D,146712540834556
Rushakoff15381254083357399137169199237256275
RJ.18281254083356275
Inpatient19171254083155392125147162197235257
Perioperative21881254083366990106144183219240273295310343377
Euglycemic258012540833269108123155186220278293325
Diabetic4251354083456193132168190205237
Ketoacidosis6751354083356992129162194209248286313328354
Due104213540834583118
to117313540832259
Sodium‑Glucose124513540833371110126163221243290306343376412439474
Cotransporter-217321354083407799120153192218257296317342376397417447
Inhibitors21931354083145290105145160183220241268
–2475135408335
Lessons25231354083316592119157195222
From27581354083325289147
a425145408332
Case4701454083397299134
Series6161454083336889104139166
and79514540833169108
Strategies9161454083335475108129163202218252279
to120814540832158
Decrease127914540834581113134168200226261
Incidence.15531454083155385100139173211243277289
Endocr185514540833370109147180201
Pract.20691454083355688120145158
2022224014540833468100135
Sep;28(9):884-888.238814540833267106119154187206239256268303338374397433468504517
doi:4251554083387692104
10.1016/j.eprac.2022.5441554083346678109141172203229245258293332353386419432468502535570582
06.11411554083357084
006.124015540833470106119
Epub137515540833271109148
2022153915540833468101136
Jun169015540832462100
23.18051554083346982
PMID:190215540833589104150163
35753675.208115540833467100133166200233266278
30.4251653085367287
Iwasaki5271654083156699125158189205
Y,74616540833544
Sasabuchi8041654083326592125164202234272288
Y,110616540833543
Horikita116316540834483104120150166189222
S,139916540833245
Furukawa14581654083336990128159192243276
T,174816540833241
Shiotsuka18031654083337186124146173211241274
J,209116540832537
Lefor21421654083316584122144
AK,23001654083417691
et240516540833456
al.24761654083314760
The255016540833272107
effect26711654083345372107139164
of284916540833756
preoperative4251754083385993131170205226258280295327361
sodium‑glucose79817540832664103117154211234274288325357393420454
cotransporter12651754083316788109142179205244282303327361381
21659175408334
inhibitors17051754083155289104143158180216238264
on198217540833775
the20691754083215994
incidence2175175408315528498137171208240273
of246117540833756
perioperative25291754083387394109147186221242274296310343376
metabolic42518540835690112143181219234248279
acidosis:7161854083316377115152177191217228
A956185408340
retrospective1008185408321547596132158195230261285299331364
cohort138418540833066103141161185
study.15811854083264885122153163
BMC175618540833488127
Endocr189518540833269107144175196
Disord.21031854083445984121142179191
202223061854083346798132
Aug245018540834076114
20;22(1):209.25761854083336678112146162193207218252285319329
doi:4251954083387692104
10.1186/s12902-022-01126-z.5441954083346678109137168203228253283313347382415436473506540561598630657687721744771785
PMID:134419540833589105150163
35987618;15231954083346799134167199229260273
PMCID:181119540833589129144190203
PMC9392326.203019540833588129163195229262297329363376
31.4252053085366880
Steinhorn5182054083325386101138175213234272
B,80220540833546
Wiener‑Kronish85820540835671103140172192210244265300336350374410
J.127720540832435
Dose‑dependent132120540834582107140161199232269303339376409445464
relationship1795205408320526696116130166202227262276313
between21172054083387292143176209245
SGLT2237220540833274104131165
inhibitor25462054083155187100137151171206226
hold27812054083387488125
time4252154083223692125
and56421540833168106
risk683215408321355988
for7842154083185575
postoperative87221540833976101123159197231251282303317348381
anion12662154083326882119156
gap143521540833869107
acidosis:15552154083316276113150175189214225
a1793215408332
single‑centre18382154083263976113127161183215247284304324357
retrospective2208215408320537494130155193227258281295326359
analysis.25802154083326899113144169183207220
Br281321540833555
J2881215408324
Anaesth.42522540834178109142168189226238
20236792254083346798132
Oct;131(4):682-686.82722540834778100112141170199213244260271305339371390426460494506
doi:1349225408338758999
10.1016/j.bja.2023.14642254083346476105135165195219234245284298329341375408439473484
06.19642254083346880
063.206022540833469101112
Epub218822540833370107145
202323492254083346798131
Aug249622540834177115
2.262722540833445
Erratum26882254083325272104124161217
in:4252354083155162
Br49923540833656
J567235408324
Anaesth.60423540834178109142167189226238
20248542354083356799129
Apr;132(4):829.9962354083417999111139168199215247263273307339371381
PMID:139023540833587101145157
37541949.15602354083346596130159187222253263
32.4252453085366983
Hamblin51824540834475131168183196233
PS,7612454083356677
Wong84824540835792129167
R,102524540833547
Ekinci10822454083336176112143156
EI,12482454083334657
Fourlanos131524540833368105125139169206242268
S,159324540833243
Shah164624540833369100136
S,179224540833344
Jones18462454083246197131156
AR,20122454083417588
et211024540833354
al.21742454083324657
SGLT2224124540833375106133167
Inhibitors24182454083155188101139153174209229255
Increase26832454083155182101134164189222
the4252554083215790
Risk5242554083354973101
of63425540833754
Diabetic6972554083455988125159179192222
Ketoacidosis9292554083346686121152182195231267292305329
Developing126725540834578108140154190227241276313
in158925540831550
the16492554083215790
Community174825540834074130185221256270290322
and207925540833167104
During219225540834581100114149186
Hospital238725540834480105141155175206219
Admission.261625540834076131145169193206242278289
J425265408324
Clin4582654083395265100
Endocrinol56726540833267104139170189202237273287
Metab.86326540835386106136173183
201910552654083346595123
Aug118726540834074111
1;104(8):3077-3087.1307265408333396796130147178194204237269299331347377409442473477
doi:1793265408337738696
10.1210/jc.2019-00139.18982654083346373102129158187209223253264298329359386408442476505533563572
PMID:24792654083358699142153
30835263.26412654083346699130161191222254264
33.4252753085367083
Kosiborod5202754083357196110147185205241279
MN,81027540835599110
Esterline9322754083325980113132147160197231
R,117427540833548
Furtado12332754083336887111142180216
RHM,146127540833579133145
Oscarsson161727540834773103135155181206243280
J,190827540832435
Gasparyan195427540834475100138169189222253290
SB,22562754083326677
Koch234427540833571103139
GG,24952754083438698
et260527540833455
al.26712754083324657
Dapagliflozin27402754083457611414542528540833852668299136162176213
in65528540831551
patients7232854083397191105138175195221
with9612854083516586123
cardiometabolic11012854083316383119133170227260281312350388402416446
risk1565285408320345988
factors16702854083185081104139159185
hospitalised187228540833875100138152173204218232256290328
with22172854083516586123
COVID-19235728540834084118133177200229258
(DARE-19):263228540831963101136168188218246263273
a425295408332
randomised,4742954083215289127163220234259292330342
double‑blind,83329540833875112149164197219257272286322360371
placebo‑controlled,12212954083395384115147185223244277312349369389425440454487525536
phase177529540833875106131165
31957295408335
trial.2009295408321415686100112
Lancet213829540833163100131163184
Diabetes23392954083466090128162183216241
Endocrinol.259729540833369107144175195209246282297308
20214253054083346798128
Sep;9(9):586-594.56630540833366104115149167198215225259292326348380411446457
doi:10363054083387589100
10.1016/S2213-8587(21)00180-7.11493054083346475104134165195218250282315345374394429461494526540573603616650685715745778801831836
Epub199830540833270107144
202121553054083346799129
Jul22973054083246074
21.23843054083346472
PMID:246930540833688102146158
34302745;26403054083346899133164196225256265
PMCID:42531540833587127140185196
PMC8294807.63431540833587126160192224259293327358363
34.4253253085367285
Sitina521325408332466781117148
M,67932540835567
Lukes7563254083316796128154
M,92032540835467
Sramek9973254083325283140173202
V.120932540833644
Empagliflozin‑associated126332540833389127158196210223239256293320334371392422448473510541555585605638676
postoperative194932540833976101123159197231251282303317348381
mixed234032540835771101133171
metabolic252132540835891112144181219233247278
acidosis.2809325408331627642533540833875100114138151
Case5873354083407197130
report7293354083205391128149172
and91233540833269106
review1030335408321538499132182
of122333540833755
pathogenesis.12903354083397091127164202236273306332345370382
BMC168433540833588128
Endocr182333540833369107144175195
Disord.20293354083466085121142178190
2023;23(1):81.22313354083346798131141175208225255268279312343351
doi:10.1186/25933354083387589100128158170199225255289312
s12902-023-01339-w.4253454083265583116150182201237268301322358388417448480502553562
35.4253553085367083
FDA52135540833276114
approves64935540833269107128163194227252
label9153554083154683117132
changes10603554083316899136173207232
to130635540832157
SGLT2137635540833376106134168
inhibitors15583554083145187101139153174210230256
regarding18273554083215392123142179193229267
temporary210735540832254111149186206238258290
discontinuation24113554083385276107143180200214250286317338352388425
of285035540833755
medication42536540835689126139169199219232268304
before7383654083387188123143175
scheduled9223654083255591124161196209242279
surgery.12103654083266079115148167198206
https://www.fda.gov/drugs/drug‑safety‑and‑availability/1426365408336567811513915017519324129234335136940543544648251854856960262165769471874177579482986688691194295899110111042106210921127116411841214124312741287130013301367138013931406142714581479
fda‑revises‑labels‑sglt2-inhibitors‑diabetes‑include‑warnings‑about‑too‑much‑acid‑blood­425375408318568710812916219320723226629231232735839643044546948951555356758862364265669373074478279681785387490091995997310031042107610971130115511751190122712581272130813461380140114521484150415411555159216301655167417061744178118181840185818791915195319752032206921002137215821892220223422722293233123462383242124592480
‑and‑serious.4253854083215288126147172206226240277313340353
Accessed79438540834172103136163190225264
March107438540835487108139177
23,12663854083346981
2020.136338540833468101135147
36.4253953085367288
BOMSS53439540833583139172204
Patient7593954083356789104139177199
Safety9783954083336685119142175
committee117439540833168127185200222247281316
Alert15103954083425792113138
on166939540833775
the17653954083226095
use18803954083386499
of200039540833756
Gliflozins.2077395408344607592109148176192230256270
https://bomss.org/23673954083385984123150163189210250289348374401414453474512539
clinical‑resources/425405408331476299114146179195217239273300338376397428462489515
March95540540835487108139177
2022.114740540833569102136149
37.4254153085367079
Peri‑Procedure5244154083356990105128164185222255289328366387421
Management96541540835487125157196231289324362384
of136841540833857
Patients14454154083356788104138177198226
on169141540833775
Sodium‑glucose178641540833271110125163221243284299337369406432467
cotransporter-222734154083316890112145183209248287308333367388408439
(SGLT2)2731415408319519512715642542540833452
Inhibitors.4954254083155391106145161183220242269282
Published79642540833572111127142168206241280
online10944254083387691106144179
December129142540834681114147205244280301
2023.161042540833469101136149
https://www.mdanderson.org/content/1777425408337598312314916218920926031336737843647550854658562064166870674575879681885688291194898610071041107911011128
dam/mdanderson/documents/for‑physicians/algorithms/clinical‑management/clin­425435408339721321592172582913303714074294574975375646016406747137738098488719009269469851008102810701110114111691185121812341267130613341361139214081448148815111527155015901649167717031733174917651804182018531887190319261987202120602093213421702230226623052328235623862402241824572480
‑management‑mgmt‑sglt2-web‑algorithm.pdf.42544540832180112150182221256314349387409428487526584606625652691707729765785837871910934966981102010591080109611181156121412271267130713261338
38.4254553085367288
Selwyn5284554083326883134168207
J,75045540832436
Pichardo‑Lowden8004554083355082120152173211250273306343394433468506
AR.13204554083417792
Managing142645540835587125158197212250289
Hospitalized172945540834483109148164186219234249278312352
Patients20964554083356788104138176198226
Taking23364554083336191107145184
SGLT2253545540833276109138173
Inhibitors:272345540831553911061451604254654083225880107119
Reducing55746540833570110147179194232271
the8404654083226095
Risk9484654083355076106
of106746540833756
Euglycemic113646540833369108123155186220277292324
Diabetic14734654083456192131167189204236
Ketoacidosis.17224654083356991128161193208246284311326352365
Diabetology.21004654083456092131167189226242279319351361
2023;4(1):86-92.247446540833468100135146181200232246258292328351386419431
doi:10.3390/diabetology4010010.4254754083387692104134165178213246279315340375390422462497519556572610650682716752784816852883915927
39.4254853085367083
Raiten5214854083356782104137175
JM,7084854083247992
Morlok81248540835492113129166196
A,102148540834054
D’Ambrosia10884854083455894152190211248274289320
S,142148540833244
Ruggero147848540833572111149183204241
MA,173148540835496110
Flood18534854083324684122161
J.202748540832436
Perioperative20754854083356889104142181216236269290305337371
Management245948540835486123155193228285319357378
of285048540833755
Patients4254954083356788104138176198225
Receiving66349540833570103136151184199237276
Sodium‑Glucose95249540833270110125162220242289304342374411437472
Cotransporter14374954083407798120153190217255294316340374395
21845495408334
Inhibitors:18924954083145290105144159182219240267280
Development218449540834681113147163201240298333371392
of258949540833756
a2658495408332
Clinical27034954083405570107122154187202
Guideline4255054083448297136171186201239274
at71250540833253
a778505408332
Large8235054083316586124159
Academic99550540834172105144179237252284
Medical129250540835489129144176209224
Center.152950540834074112133167188199
J1741505408324
Cardiothorac17785054083407294132147185207245283305337370
Vasc21615054083356693125
Anesth.229950540834179114141164202215
2024;38(1):5766.2527505408335691021331451802152342652802913273604255154083347083
doi:10.1053/j.jvca.2023.5235154083387792104134165178209240274307332348361377410441474487523557590625637
10.11765154083346578
011.12695154083346694103
40.3047553085367489
Khunti31555540833574112150171187
K,33615540833550
Aroda34305540834163100139172
VR,3621554083367387
Bhatt37275540833674106128152
DL,3899554083457891
Bozkurt40105540833574102132170192216
B,42465540833548
Buse4314554083357399134
JB,4468554083246073
Heerspink45605540834479115136163202218256286
HL,4865554083447690
et49755540833456
al.5050554083324860
Re‑examining5130554083357094130162194252267305320358397
the3047654083226196
widespread31646540835167107142170209231266299338
policy3523654083397995110143177
of37216540833857
stopping3799654083275088128169184223263
sodium‑glucose40836540832665105121159218241282298336368406433469
cotransporter-24573654083316991113147185212252291313339373395415446
inhibitors5040654083155492108147163186224246274
during5335654083387698114153192
acute30477540833264102124158
illness:321975408315304583118145171184
A341775408341
perspective3472754083397596123162198230254270302337
based3823754083387198133173
on40107540833776
the4100754083216095
updated42097540833776116148170204243
evidence.4466754083346782121156194226260272
Diabetes4753754083456092132167189223250
Obes50177540834787123149
Metab.51817540835489112144184196
202253917540833469101136
Nov;24(11):2071-2080.30478540834583115128163195214246274288300335369402434453484518554589601
doi:3664854083387691104
10.1111/dom.14805.3783854083346678109137164192214249287346359390421457492526538
Epub43368540833372110149
202245018540833468101136
Aug46528540834178117
4.47848540833447
PMID:48468540833589105150163
35801339.50258540833467101136168198231264275
41.3047953085366981
ElSayed3142954083334880113144178218
NA,33739540834586100
Aleppo3487954083415791131170209
G,37109540834357
Aroda3781954083416299139171
VR,3966954083357286
Bannuru40669540833568106144182203241
RR,4321954083357286
Brown4421954083355694145183
FM,4618954083328699
Bruemmer4731954083355695130188245280302
D,50469540834657
et51169540833457
al;5186954083324859
on52599540833776
behalf53489540833975113145161180
of304710540833756
the31161054083215994
American322310540834198133154169201234271
Diabetes35071054083456192131167189222249
Association.37691054083406894132165180211233248286324337
16.41191054083346578
Diabetes42091054083466193132167189222249
Care44711054083397293127
in461110540831452
the46751054083226095
Hospital:478210540834482109147163185218233245
Standards50391054083335486124163195216254280
of533110540833757
Care54001054083407394127
in304711540831552
Diabetes-2023.31121154083456092131166189222249269300334367401413
Diabetes35381154083456192131167189222249
Care.38001154083397293127139
2023395211540833467100135
Jan40991154083245694
1;46(Suppl42061154083344276112131162200238278293
1):S267-S278.4512115408334486094127160193211242275308341355
doi:48791154083387691103
10.2337/dc23-S016.49951154083346578113148181213232268300335369391422457489519533
PMID:304712540833589104150163
36507644;322612540833468102136169201237274286
PMCID:352712540833589130145190203
PMC9810470.374612540833589129163198230261298330363375
42.30471353085367086
Guideline31501354083448297136171186201239274
for34411354083185677
Perioperative35351354083356990106144183219240273295310342377
Care39281354083407394128
for40731354083185678
People416713540833669108147163198
with43821354083506688127
Diabetes45251354083466193132168190224251
Mellitus479313540835489105120135157195221
Undergoing503113540834482121156177215253269306345
Elective5393135408333488311530471454083223769104
and316714540833270109
Emergency329214540833290125146184219257290323
Surgery.36311454083337091129164185219229
Published387714540833572111127142168206241280
online41731454083387691106144179
October436814540834780104141181216237
2023.462214540833468101135148
https://www.cpoc.org.uk/47861454083385983123150162189209260314367378410449488520534572593632645682712741
sites/cpoc/files/documents/2024-03/CPOC‑DiabetesGuideline2023.pdf.3047155408326416397124150179218257289316334351366401428454489528560598656691729751778804839873906938961998103110551094113011771219123212791295132713661402142414581485152915671582162116561671168617241759179418281860189519081948198720072018
43.30471653085367186
Crowley31481654083406198149165200231
K,339416540833549
Scanaill34581654083326597136168183198213
PÓ,36861654083358394
Hermanides379416540834479101159191229244283318345
J,415316540832537
Buggy420416540833573112151183
DJ.44021654083456880
Current44971654083397697119153191213
practice47241654083396093125150165197231
in496916540831553
the50361654083226095
perioperative51451654083397596111149189224246279300316348383
management304717540835688125157193226281314350369
of342617540833654
patients34891754083386988102134170189215
with37131754083506484120
diabetes38421754083385181118151171203227
mellitus:407917540835689103116129149185209219
a4308175408331
narrative43491754083366786105136156169199231
review.4590175408320528296128177186
Br478517540833554
J4849175408323
Anaesth.488217540834076106139163185220232
2023;131(2):242252.5123175408334659612913816619422323626728329332635638630471854083346899110
doi:10.1016/j.bja.2023.31701854083387589100128158169199229259289312327339378392422434469501533566577
02.37601854083346677
039.38491854083346698108
44.30471953085357184
NSW314119540834474129
Agency327919540834076109144174205
for34931954083185373
Clinical35751954083395265100113143173186
Innovation.37711954083145085121150181200214249285296
Use40761954083436699
of418419540833754
SGLT2‑inhibitors424719540833273103130163181195230266279315329349384403428
for46841954083185372
type47661954083215289123
24898195408333
diabetes49401954083385180117150170201226
in517519540831450
acute52341954083316196116148
inpatient5391195408314508611730472054083213467102122
care:31782054083316180112122
Clinical33092054083395365101114143174187
practice35052054083385888118140153183214
guide.37282054083387386122155165
Sydney:39022054083326095131164193204
ACI;41152054083417790100
2023.42242054083346696128139
https://aci.health.nsw.gov.au/__data/assets/437220540833756781151401501751932212512642753113443733874074424544905145635726086446736817137487727998368739039239539771005102910541086110611321155
pdf_file/0010/825085/ACI‑Use‑of‑SGLT2-inhibitor‑medicines‑for‑people‑with‑diabetes.pdf.3047215408339779512914516217620923426630133136138441744948351554958260464067869271375778181583787589391294298510151043107710961111114711841198123512501271130613261345140214361474148815181532156816021627164716651701172217401778181318501888190319361958200820222043208021012140215421852222225722772310233523472386242424422452
45.30472253085377387
Guidelines31532254083458398137172187201239274301
of347322540833857
Australian354922540834279105128149182197211243282
diabetes38492254083405486125161183217243
society.41112254083276698113148170203213
https://www.diabetessociety.com.au/wp­43422254083396084124150162189209260314368378418432464504539561595621648686719733768790824833865902961974100810451071112311631186
‑content/uploads/2023/05/ADS‑ADEA‑ANZCA‑NZSSD_DKA_SGLT2i_Alert_Ver‑May-2023.pdf.30472354083215287124143175211231257291328342378409446471494527560590623646677710732767811841862901945976101710371076111911551191123212511295133113631394143714701515154915911628166117031733176017941806184118841897193019501972200820402071209121082162219322222242227123032334236723772415245324712480
46.30472453085367287
Milder31512454083546882120153173
DA,33412454083468497
Milder34552454083546882120153173
TY,36452454083337077
Kam373924540833568124
PCA.388024540833575116129
Sodium‐glucose402624540833370108122158214235274288324355391416450
co‐transporter44932454083316688109129161198223260298318341373393
type‐249032454083225493127149178
inhibitors:50992454083145187101139153174209230255267
pharmacology538324540833876106126304725540835788119155169206244275
and333925540833269106
peri‐operative34632554083387392107127166204238258289310324355388
considerations.386825540833267104129142180213233265285299336373398410
Anaesthesia.429525540834178109143168190227260286299330341
2018;73(8):1008-1018.46542554083346797127138169202219251268278306336371405427456486516546558
doi:10.1111/5230255408338758999128158169198225251277297
anae.14251.30472654083326899133144173203234267297305
47.30472753085366976
Seki31372754083326695110
H,326127540834455
Ideno33302754083155286122159
S,350327540833244
Shiga35602754083336983120151
T,372527540833240
Watanabe377827540835888108140176207245279
H,407127540834455
Ono414027540834784121
M,427527540835466
Motoyasu435527540835491112147177209234270
A,463827540834154
et470527540833455
al.47742754083324657
Sodium‑glucose484527540833269107121157214235274288324355390415449
cotransporter5308275408331668710713817520030472854083397696120152172
23233285408334
inhibitor‑associated32812854083155288102140154175210230249280305330367398412442463495533
perioperative38292854083387292106143181215235267287301332365
ketoacidosis:42082854083306384119151181195233269295308333344
a4566285408332
systematic46122854083265783105137194225245259289
review4916285408320538498132181
of511228540833755
case51812854083316388121
reports.53172854083205391128149172198210
J3047295408324
Anesth.308729540834178111137158195207
202333102954083346798131
Jun;37(3):465-473.34572954083246197108142172187219235246279313346366402432465476
doi:3949295408338758999
10.1007/s00540-023-03174-8.40642954083346476105135170201220243276311343377412434470501535555591623652680709731766778
Epub485729540833370107145
202350182954083346798131
Feb516529540833365103
27.52842954083346570
PMID:537029540833587102146158
36849747;304730540833467101136168199228259267
PMCID:332730540833587127140185196
PMC10229478.353630540833587126157187219252285319350382394
48.30473153085367286
Bobrowski314331540833572109129165214239267282
D,343531540834554
Kumar349931540833570126156176
R,368531540833547
Wu374231540835792
PE,38443154083356577
Lapointe‑Shaw393131540833162100137151187206238260289325356405
L.434531540833244
Prolonged43983154083355490104140177214247285
ketosis46933154083296282117142155180
and488331540833167105
glycosuria49983154083375181111146171206226240270
secondary52783154083265990125161199229304732540832153
to311332540832157
SGLT2318332540833275106133167
inhibitor33633254083155188101139153174210230
therapy.36063254083215892111143181211219
Clin38383254083405367104
Case39543254083407197130
Rep.409732540833569106118
2021;9(11):e05057.42273254083346798128135169187217244257267300335367400433465469
doi:10.1002/ccr3.5057.47093254083387589100128158169198229263295320347377397427438472504537569574
49.30473353085367387
Pujara31573354083357390123145179
S,335933540833246
Ioachimescu34283354083145488121160176235271299332371
A.382233540834156
Prolonged39013354083355795112151191231267307
Ketosis42313354083357094132159175202
in445633540831554
a4532335408332
Patient45863354083356891108143183205
With48143354083577498137
Euglycemic497433540833270110126159192226285302335
Diabetic5331335408345629513517230473454083223872
Ketoacidosis31423454083357195133168201218258298326342370
Secondary353534540833369103142182223256279315
to387234540832261
Dapagliflozin.395634540834679120154195212228247264304334351390405
J4384345408324
Investig44313454083155487123151176193233
Med468734540835592133
High484334540834461101141
Impact500734540831474115149183209
Case523834540834175103140
Rep.540134540833572113127
2017;5(2):2324709617710040.304735540833469102133143180198233252265301337371404437471507544575605641674707744781818832
doi:10.1177/2324709617710040.38973554083387793106137170183215244274310331367403436469502537573609641671707740773810847884898
50.30473653085367389
Bonanni315836540833575114148187226242
FB,34213654083326982
Fei35243654083336884
P,362936540833541
Fitzpatrick36913654083334972104145179201224241274305
LL.40173654083316479
Normoglycemic411736540834584107167206247263296328363422438471
ketoacidosis46093654083306588126160194210250289317333360
in499036540831554
a5065365408332
postoperative511836540833878106130168209246268302325341375410
gastric30473754083387199123146162195
bypass326437540833971112146174202
patient34883754083387295111147186209
taking37193754083215587104143183
canagliflozin.392437540833165104138178194210229246285314331370384
Surg43303754083327193132
Obes448437540834788125152
Relat46583754083367288122145
Dis48253754083456189
Off49363754083476887
J5045375408325
Am5092375408340100
Soc521337540833372106
Bariatr53413754083356992108141164187
Surg.30473854083327193132146
2016;12(1):e11-12.321138540833469102134147179210228261276289325355384404436467480
doi:10.1016/j.soard.2015.37093854083387794107138170184215248281313339356370399438472494534548585620653684697
08.44233854083347185
502.452638540833469103117
51.30473953085367184
Scheen315039540833266105141177217
AJ.33863954083416982
Use348839540834370106
of361339540833858
SGLT2369039540833378111141178
inhibitors38873954083155493109149166189227250278
after41843954083325278113135
bariatric/metabolic43393954083387294111144167189206239267325361384418458498515531564
surgery:49223954083266587126162184219234
Risk/benefit51753954083365279110140181218257293312329352
balance.30474054083397389122161195229243
Diabetes33074054083456295135172195230258
Metab.358240540835591114148188202
2023;49(4):101453.380140540833470104139152188222242276294307338371404436470504517
doi:10.1016/j.diabet.2023.101453.43364054083387793107137170184215248281313339356370410427460500536560574611646680716730761794827859893927940
52.30474153085367288
Meyer315041540835490122157180
EJ,33444154083336073
Mignone343241540835470110149188227263
E,371041540833246
Hade377141540834477117152
A,393841540834156
Thiruvenkatarajan40094154083327288110149182217256287321344378400433450482521
V,454541540833545
Bryant46054154083355792126165187
RV,48074154083357282
Jesudason49044154083246087125165198225264304
D.522241540834658
Periprocedural52944154083357092108148170208304742540833166107145167201218
Euglycemic328342540833370111127160192227286302335
Diabetic36374254083456295135171195211244
Ketoacidosis39004254083347093131165198215254294321337365
Associated42834254083417098137171187220243277318
With46194254083587599138
Sodium‑Glucose477542540833372113129167226250297314353386424452488
Cotransporter528142540834078101124158197224304743540833979101127162184
23249435408334
Inhibitor33004354083155493109149166190228250
Therapy356843540833273109131165205237
During382343540834585107124163203
Colonoscopy.40434354083407895134174213241274312353385396
Diabetes44574354083456295135172195230258
Care.47324354083407496131145
2020;43(11):e181-e184.489443540833469103138152188222241274302318331366397429462482519550582620633
doi:10.2337/dc20-1244.30474454083387794107138170184221257291324345382415451487512543574607645659
53.30474553085367288
Hamblin315145540834478136177194210249
PS,34164554083356983
Wong351545540835794134174
R,370545540833550
Ekinci37714554083336481120154170
EI,39574554083324862
Sztal‑Mazer40354554083336288122138162219252283318340
S,439145540833347
Balachandran44544554083356986119152191224263304326360399
S,486945540833246
Frydman49314554083335388128187220259
A,520645540834156
et527845540833458
al.53524554083324862
Capillary5430455408340743047465408338547085118139173
Ketone32354654083346891128167202
Concentrations345146540833976115147181219241263296318334372411437
at390346540833153
the39704654083216095
Time407946540833249107142
of423546540833757
Colonoscopy:43064654083397693131169208235267304344376390
A4710465408340
Cross‑Sectional47644654083406198125152173205240273297313351390422438
Study52164654083325492131163
With53934654083577396134
Implications304747540831573112129145177210233249287326353
for34154754083185678
SGLT2350847540833277109139175
Inhibitor‑Treated36984754083145391107147163186223246266297315349382404438478
Type41914754083325999134
24337475408334
Diabetes.43844754083446091130165187220246259
Diabetes46564754083456092130165187220247
Care.49154754083407293126138
202150664754083346799130
Jun;44(6):e124-e126.5209475408324619911014418120023325026229630474854083346395117153182212245258
doi:33174854083387590102
10.2337/dc21-0256.34324854083336477112146179210230265297332362381417450484518531
Epub397548540833371108147
2021413448540833468100131
Apr427848540834079100
25.43914854083336879
PMID:448348540833588103148161
33896795;465648540833466100134169201234267278
PMCID:494648540833588128143188201
PMC8247528.515948540833588128162195226258290322356369
54.30474953085367388
Dizon31544954083456190127166
S,333849540833245
Keely340149540833569105120152
EJ,35714954083335971
Malcolm366049540835587103135172188245
J,392349540832537
Arnaout397849540834162101133171209232
A.422849540834155
Insights4302495408314527993132170192220
Into45404954083145274111
the46694954083226095
Recognition478249540833570103140179217232255270308347
and514749540833169109
Management527449540835487125157196231304750540835792130151
of321150540833756
SGLT2-Inhibitor‑Associated328050540833277108137173193209247285300339354376413434454495523549587620635666688721761
Ketoacidosis:40545054083346891127160192207246284310325351363
It’s4430505408315375277
Not451950540834583105
Just46375054083246187110
Euglycemic476050540833369108123154186219277292324
Diabetic50965054083456193132167189204236
Ketoacidosis.5345505408335699112816030475154083314685123150165191205
Can326751540834073111
J3393515408324
Diabetes.34335154083456092132167189223250264
2017;41(5):499-503.371251540833468100129139174204219253271283317351386409443478511523
doi:10.1016/j.jcjd.2017.42505154083397792104134166178209240272303328345358374406421460473509543575604610
05.48765154083346880
004.497151540833471107119